Johnson & Johnson Plans Spin-Off of $9.2 Billion Orthopedics Unit

The company’s orthopedics division generated $9.2 billion in sales in 2024, and will be separated as part of a planned corporate restructuring.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Spin-Off: A corporate action where a company creates an independent company by separating part of its operations into a new entity.
  • Orthopedics Unit: A business segment focused on medical devices and solutions for musculoskeletal conditions.